DE602005008419D1 - Verwendung von meloxicam-formulierungen in der veterinärmedizin - Google Patents
Verwendung von meloxicam-formulierungen in der veterinärmedizinInfo
- Publication number
- DE602005008419D1 DE602005008419D1 DE602005008419T DE602005008419T DE602005008419D1 DE 602005008419 D1 DE602005008419 D1 DE 602005008419D1 DE 602005008419 T DE602005008419 T DE 602005008419T DE 602005008419 T DE602005008419 T DE 602005008419T DE 602005008419 D1 DE602005008419 D1 DE 602005008419D1
- Authority
- DE
- Germany
- Prior art keywords
- meloxicamic
- formulations
- veterinary medicine
- veterinary
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004021281A DE102004021281A1 (de) | 2004-04-29 | 2004-04-29 | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
PCT/EP2005/004344 WO2005105101A1 (en) | 2004-04-29 | 2005-04-22 | Use of meloxicam formulations in veterinary medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005008419D1 true DE602005008419D1 (de) | 2008-09-04 |
Family
ID=34966064
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE102004021281A Withdrawn DE102004021281A1 (de) | 2004-04-29 | 2004-04-29 | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
DE602005008419T Active DE602005008419D1 (de) | 2004-04-29 | 2005-04-22 | Verwendung von meloxicam-formulierungen in der veterinärmedizin |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE102004021281A Withdrawn DE102004021281A1 (de) | 2004-04-29 | 2004-04-29 | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
Country Status (21)
Country | Link |
---|---|
US (1) | US20050245510A1 (de) |
EP (2) | EP1744756B1 (de) |
JP (1) | JP2007534717A (de) |
KR (2) | KR20070036056A (de) |
CN (1) | CN1950090A (de) |
AR (1) | AR048718A1 (de) |
AT (1) | ATE401891T1 (de) |
AU (1) | AU2005237230B2 (de) |
BR (1) | BRPI0510449A (de) |
CA (1) | CA2562379A1 (de) |
CY (1) | CY1108421T1 (de) |
DE (2) | DE102004021281A1 (de) |
DK (1) | DK1744756T3 (de) |
ES (1) | ES2310822T3 (de) |
MX (1) | MXPA06012303A (de) |
NZ (1) | NZ551313A (de) |
PL (1) | PL1744756T3 (de) |
PT (1) | PT1744756E (de) |
SI (1) | SI1744756T1 (de) |
UY (1) | UY28872A1 (de) |
WO (1) | WO2005105101A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
US8512727B2 (en) | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
EP1568369A1 (de) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen |
DE102004030409A1 (de) * | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
NZ567627A (en) * | 2005-09-30 | 2011-08-26 | Boehringer Ingelheim Vetmed | Granulation process for making a divisible tablet containing meloxicam |
MX340669B (es) * | 2008-09-09 | 2016-07-20 | Cima Labs Inc | Formas farmaceuticas para compuestos debilmente ionizables. |
TR200809200A1 (tr) | 2008-12-01 | 2009-12-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Meloksikam içeren farmasötik formülasyonlar |
CA2763456C (en) | 2009-05-27 | 2017-10-24 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
IN2012DN03157A (de) | 2009-10-12 | 2015-09-18 | Boehringer Ingelheim Vetmed | |
AU2010347598B2 (en) | 2010-03-03 | 2014-11-27 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
WO2012009542A2 (en) | 2010-07-14 | 2012-01-19 | Kansas State University Research Foundation | Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration |
CN103260620A (zh) | 2010-12-27 | 2013-08-21 | 英特维特国际股份有限公司 | 包含三缩四乙二醇的外用局部异噁唑啉制剂 |
CN102908310A (zh) * | 2012-11-02 | 2013-02-06 | 青岛康地恩药业股份有限公司 | 一种犬、猫用治疗类风湿性关节炎的美洛昔康注射液 |
JP2019163249A (ja) * | 2018-03-16 | 2019-09-26 | フジタ製薬株式会社 | メロキシカム水性溶液 |
US20210106591A1 (en) * | 2018-05-11 | 2021-04-15 | Nanjing Delova Biotech Co. Ltd. | Meloxicam composition, preparation and preparation method and use thereof |
RU2725773C1 (ru) * | 2019-12-24 | 2020-07-06 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" | Препарат для профилактики и лечения воспалительных процессов у животных |
Family Cites Families (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2795529A (en) * | 1954-06-17 | 1957-06-11 | American Home Prod | Stabilized hyaluronidase solution containing calcium chloride |
US3288675A (en) * | 1964-03-20 | 1966-11-29 | Hoffmann La Roche | Parenteral sulfonamide compositions and processes |
BE789726A (fr) * | 1971-10-06 | 1973-04-05 | Merck & Co Inc | Suppositoires a l'indomethacine |
DE2756113A1 (de) | 1977-12-16 | 1979-06-21 | Thomae Gmbh Dr K | Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
IL58461A0 (en) * | 1978-10-27 | 1980-01-31 | Beecham Group Ltd | Intramammary compositions comprising a clavulanic acid salt |
ZA80796B (en) * | 1979-02-13 | 1981-02-25 | Leo Pharm Prod Ltd | Chemical compounds |
DE3217315C2 (de) * | 1982-05-08 | 1986-05-22 | Gödecke AG, 1000 Berlin | Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten |
US4543200A (en) * | 1983-09-28 | 1985-09-24 | Sherman Laboratories, Inc. | Contact lens preservative system cleaner and method |
DE3580140D1 (de) * | 1984-03-14 | 1990-11-22 | Jerome Corbiere | Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel. |
DE3437232A1 (de) * | 1984-10-10 | 1986-04-17 | Mack Chem Pharm | Stabilisierte injektionsloesungen von piroxicam |
IT1207994B (it) * | 1986-01-03 | 1989-06-01 | Therapicon Srl | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. |
IT1216686B (it) * | 1988-04-01 | 1990-03-08 | Chiesi Farma Spa | Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione. |
EP0418596A3 (en) * | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
HU205550B (en) * | 1990-11-27 | 1992-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing pyroxycam solution of increased stability, free from effects damaging tussues |
US8178516B2 (en) * | 1992-06-30 | 2012-05-15 | Sylvan Labs, LLC | Compositions and method for treatment of chronic inflammatory diseases |
US5380934A (en) * | 1992-10-29 | 1995-01-10 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing alanylgutamine |
US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
AU730495B2 (en) * | 1995-11-13 | 2001-03-08 | North West University | Administration media for analgesic, antiinflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
US6187800B1 (en) * | 1996-06-20 | 2001-02-13 | Novartis Animal Health U.S., Inc. | Method for the prevention and treatment of mastitis |
US6709678B2 (en) * | 1996-08-15 | 2004-03-23 | Losan Pharma Gmbh | Easy to swallow oral medicament composition |
US6071539A (en) * | 1996-09-20 | 2000-06-06 | Ethypharm, Sa | Effervescent granules and methods for their preparation |
US6090800A (en) * | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
KR20010023256A (ko) * | 1997-08-27 | 2001-03-26 | 헥살 아게 | 용해도와 생체 이용성이 개선된 신규의 멜록시캄 의약조성물 |
DE69819351D1 (de) * | 1997-09-11 | 2003-12-04 | Nycomed Danmark As Roskilde | Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids) |
RS49982B (sr) * | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
SE9703693D0 (sv) * | 1997-10-10 | 1997-10-10 | Astra Pharma Prod | Novel combination |
US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
US6184220B1 (en) * | 1998-03-27 | 2001-02-06 | Boehringer Ingelheim Pharma Kg | Oral suspension of pharmaceutical substance |
EP0945134A1 (de) | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation |
US6369049B1 (en) * | 1998-04-30 | 2002-04-09 | Eli Lilly And Company | Treatment of mastitis |
EP1082966A4 (de) * | 1998-05-15 | 2004-07-21 | Wakamoto Pharma Co Ltd | Entzündungshemmende augentropfen |
US6319519B2 (en) * | 1998-07-07 | 2001-11-20 | Norton Healthcare Ltd. | Anti-inflammatory pharmaceutical formulations |
DE19847968A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen |
GB9823246D0 (en) * | 1998-10-24 | 1998-12-16 | Danbiosyst Uk | A nasal drug delivery composition |
US6180136B1 (en) * | 1998-11-10 | 2001-01-30 | Idexx Laboratories, Inc. | Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
US6183779B1 (en) * | 1999-03-22 | 2001-02-06 | Pharmascience Inc. | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin |
US6166012A (en) * | 1999-07-30 | 2000-12-26 | Allergan Sales, Inc. | Antibiotic compositions and method for using same |
FR2798289B1 (fr) * | 1999-09-15 | 2004-12-31 | Cll Pharma | Formes galeniques a delitement rapide en bouche et leur procede de preparation |
AU1548001A (en) * | 1999-11-24 | 2001-06-04 | Wakamoto Pharmaceutical Co., Ltd. | Ophthalmic aqueous preparation |
WO2001083093A1 (en) * | 2000-05-03 | 2001-11-08 | Silva Joe D | Process and device for producing liquid dosage formulations |
AU2001259974A1 (en) * | 2000-05-15 | 2001-11-26 | Merck Frosst Canada & Co | Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
AU2001264729A1 (en) * | 2000-05-22 | 2001-12-03 | Nitromed, Inc. | Thromboxane inhibitors, compositions and methods of use related applications |
US20020035107A1 (en) * | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
US6375982B1 (en) * | 2000-07-05 | 2002-04-23 | Capricorn Pharma, Inc. | Rapid-melt semi-solid compositions, methods of making same and method of using same |
JP2004503588A (ja) * | 2000-07-13 | 2004-02-05 | ファルマシア・コーポレーション | 全身性疼痛および頭痛に対する選択的シクロオキシゲナーゼ−2阻害薬および血管調節化合物 |
ES2223209B1 (es) * | 2001-12-11 | 2005-10-01 | Esteve Quimica, S.A. | Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion. |
US20040204413A1 (en) * | 2001-01-26 | 2004-10-14 | Joaquina Faour | Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant |
AU2002306868A1 (en) * | 2001-03-28 | 2002-10-15 | Pharmacia Corporation | Therapeutic combinations for cardiovascular and inflammatory indications |
US20020187187A1 (en) * | 2001-04-21 | 2002-12-12 | Toshimitsu Ohki | Fast disintegrating meloxicam tablet |
US7179627B2 (en) * | 2001-09-28 | 2007-02-20 | Brigham Young University | Cyclooxygenase variants and methods of use |
US20040253312A1 (en) * | 2001-09-28 | 2004-12-16 | Sowden Harry S. | Immediate release dosage form comprising shell having openings therein |
DE10161077A1 (de) * | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US20040001883A1 (en) * | 2002-03-30 | 2004-01-01 | Boehringer Ingelheim International Gmbh | Meloxicam suppositories |
US20040024042A1 (en) * | 2002-04-02 | 2004-02-05 | Vanderbilt University | COX2 inhibition in the prevention and treatment of autosomal dominant polycystic kidney disease |
DE10223013A1 (de) * | 2002-05-22 | 2003-12-04 | Boehringer Ingelheim Int | Verwendung von Meloxicam für die Linderung von Organverletzungen während Organoperation oder -transplantation |
EP1536777B1 (de) * | 2002-08-14 | 2007-02-14 | Janssen Pharmaceutica N.V. | Verwendung von nf-kappa b hemmern zur behandlung von brustdrüsenentzündung |
US20040037869A1 (en) * | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
CA2499093A1 (en) * | 2002-09-17 | 2004-04-01 | Nippon Boehringer Ingelheim Co., Ltd. | Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer. |
US20040171611A1 (en) * | 2002-09-30 | 2004-09-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline acetic acid solvate of meloxicam |
US8992980B2 (en) * | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
CA2413705A1 (en) * | 2002-12-06 | 2004-06-06 | Raul Altman | Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions |
US20050197332A1 (en) * | 2002-12-10 | 2005-09-08 | Boehringer Ingelheim International | Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions |
US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
US20040204472A1 (en) * | 2003-03-04 | 2004-10-14 | Pharmacia Corporation | Treatment and prevention of obesity with COX-2 inhibitors alone or in combination with weight-loss agents |
US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
US20040198826A1 (en) * | 2003-04-07 | 2004-10-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical combination for treating benign prostatic hyperplasia or for treating abacterial prostatitis |
US20050038018A1 (en) * | 2003-07-09 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Meloxicam compositions |
US20050147664A1 (en) * | 2003-11-13 | 2005-07-07 | Elan Pharma International Ltd. | Compositions comprising antibodies and methods of using the same for targeting nanoparticulate active agent delivery |
EP1568369A1 (de) * | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen |
DE102004025324A1 (de) * | 2004-05-19 | 2005-12-08 | Boehringer Ingelheim Vetmedica Gmbh | Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung |
DE102004030409A1 (de) * | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
US20060217431A1 (en) * | 2005-03-23 | 2006-09-28 | Boehringer Ingelheim International Gmbh | Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a COX-2 inhibitor |
NZ567627A (en) * | 2005-09-30 | 2011-08-26 | Boehringer Ingelheim Vetmed | Granulation process for making a divisible tablet containing meloxicam |
IN2012DN03157A (de) * | 2009-10-12 | 2015-09-18 | Boehringer Ingelheim Vetmed | |
US9795568B2 (en) * | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
-
2004
- 2004-04-29 DE DE102004021281A patent/DE102004021281A1/de not_active Withdrawn
-
2005
- 2005-04-22 AT AT05736533T patent/ATE401891T1/de active
- 2005-04-22 CA CA002562379A patent/CA2562379A1/en not_active Abandoned
- 2005-04-22 EP EP05736533A patent/EP1744756B1/de active Active
- 2005-04-22 WO PCT/EP2005/004344 patent/WO2005105101A1/en active IP Right Grant
- 2005-04-22 CN CNA200580013754XA patent/CN1950090A/zh active Pending
- 2005-04-22 NZ NZ551313A patent/NZ551313A/en not_active IP Right Cessation
- 2005-04-22 KR KR1020067025162A patent/KR20070036056A/ko active Application Filing
- 2005-04-22 KR KR1020137010927A patent/KR20130050394A/ko not_active Application Discontinuation
- 2005-04-22 PL PL05736533T patent/PL1744756T3/pl unknown
- 2005-04-22 DE DE602005008419T patent/DE602005008419D1/de active Active
- 2005-04-22 MX MXPA06012303A patent/MXPA06012303A/es active IP Right Grant
- 2005-04-22 ES ES05736533T patent/ES2310822T3/es active Active
- 2005-04-22 BR BRPI0510449-1A patent/BRPI0510449A/pt not_active IP Right Cessation
- 2005-04-22 EP EP08157816A patent/EP1980253A1/de not_active Withdrawn
- 2005-04-22 AU AU2005237230A patent/AU2005237230B2/en not_active Ceased
- 2005-04-22 SI SI200530371T patent/SI1744756T1/sl unknown
- 2005-04-22 PT PT05736533T patent/PT1744756E/pt unknown
- 2005-04-22 JP JP2007509944A patent/JP2007534717A/ja active Pending
- 2005-04-22 DK DK05736533T patent/DK1744756T3/da active
- 2005-04-26 UY UY28872A patent/UY28872A1/es not_active Application Discontinuation
- 2005-04-26 US US11/114,417 patent/US20050245510A1/en not_active Abandoned
- 2005-04-29 AR ARP050101706A patent/AR048718A1/es active Pending
-
2008
- 2008-10-16 CY CY20081101150T patent/CY1108421T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE102004021281A1 (de) | 2005-11-24 |
PL1744756T3 (pl) | 2009-01-30 |
SI1744756T1 (sl) | 2008-10-31 |
CA2562379A1 (en) | 2005-11-10 |
CN1950090A (zh) | 2007-04-18 |
KR20070036056A (ko) | 2007-04-02 |
AU2005237230A1 (en) | 2005-11-10 |
EP1744756A1 (de) | 2007-01-24 |
AU2005237230B2 (en) | 2011-01-06 |
MXPA06012303A (es) | 2007-05-04 |
KR20130050394A (ko) | 2013-05-15 |
BRPI0510449A (pt) | 2007-10-30 |
DK1744756T3 (da) | 2008-11-24 |
AR048718A1 (es) | 2006-05-17 |
NZ551313A (en) | 2010-07-30 |
WO2005105101A1 (en) | 2005-11-10 |
JP2007534717A (ja) | 2007-11-29 |
US20050245510A1 (en) | 2005-11-03 |
EP1744756B1 (de) | 2008-07-23 |
EP1980253A1 (de) | 2008-10-15 |
ES2310822T3 (es) | 2009-01-16 |
CY1108421T1 (el) | 2014-04-09 |
UY28872A1 (es) | 2005-11-30 |
ATE401891T1 (de) | 2008-08-15 |
PT1744756E (pt) | 2008-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005008419D1 (de) | Verwendung von meloxicam-formulierungen in der veterinärmedizin | |
LTPA2017004I1 (lt) | Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai | |
DK1917246T3 (da) | Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme | |
ATE289514T1 (de) | Vaginalpflegezusammensetzung | |
ATE450243T1 (de) | Haarpflegezusammensetzung | |
IS8597A (is) | Samsetningar rísedrónats og aðferðir við notkun þess | |
DK1830926T3 (da) | Oreganomundplejesammensætninger og fremgangsmåde til anvendelse heraf | |
ATE524183T1 (de) | Verwendung von sanglifehrin bei der hcv-therapie | |
ATE512970T1 (de) | Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung | |
ATE411046T1 (de) | Injizierbare veterinärmedizinische zusammensetzung enthaltend florfenicol | |
DE50308640D1 (de) | Veterinärmedizinische spritze | |
DE502004011575D1 (de) | Verwendung von Dioldimerfettsäureestern | |
DE602006007995D1 (de) | Formulierungen von liponsäure und hyaluronsäurebeneichen | |
ATE411817T1 (de) | Benzothiazolformulierungen und ihre verwendung | |
NO20043576L (no) | Pharmaceutical formulation comprising melatonin | |
ATE443512T1 (de) | Pharmazeutische zusammensetzung von piperazinderivaten | |
ATE413396T1 (de) | Pyrazindicarbonsäureamide und ihre verwendung | |
DK1617876T3 (da) | Thorium-227 til anvendelse i strålebehandling af bløddels-sygdomme | |
IS7902A (is) | Blettaeyðandi samsetning fyrir húðumhirðu | |
DE60316792D1 (de) | Pharmazeutische verwendung von cox-2-hemmern in angiogenese-vermittelten augenerkrankungen | |
FI20040750A0 (fi) | Prepreg ja sen käyttö | |
ITMI20041447A1 (it) | Composizione farmaceutica comprendente gabapentina | |
ATE456573T1 (de) | Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen | |
ITMI20042130A1 (it) | Composizione farmaceutica e cosmetica | |
FI20031845A0 (fi) | Alfa-1-adrenoseptori-antagonistien uusi terapeuttinen käyttö |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |